News

Amicus Therapeutics’ first oral drug for the rare condition Fabry disease has been approved by the FDA, giving patients an alternative to conventional injected enzyme replacement therapy.
Sangamo plans to file for approval of its gene therapy for Fabry disease next year, but a launch could depend on finding a commercial partner.
Polish astronaut Slawosz Uznanski-Wisniewski (L) and Hungarian astronaut Tibor Kapu gesture at relatives as he makes his way to Launch Complex 39A ahead of the Axiom-4 mission, with a SpaceX ...
SpaceX’s fifth and final Crew Dragon spacecraft finally made it off the ground on a private astronaut mission for Axiom Space.
Penn State has hit the international market in a big way to fill another overhauled roster under coach Mike Rhoades, and the Nittany Lions struck again Tuesday. Slovenian forward Tibor Mirtic ...
Fabry disease is a disorder of glycosphingolipid metabolism caused by deficiency of lysosomal α–galactosidase A (α–Gal A), resulting in renal failure along with premature myocardial ...
🇭🇺 Tibor Kapu has arrived at the International Space Station! The Hungarian astronaut reached the ISS aboard SpaceX’s Crew Dragon spacecraft as part of the Ax-4 mission — a historic moment for ...
In this communication, we propose a dual-band Fabry-Perot (F-P) cavity antenna with a wideband low radar cross section (RCS) by integrating a Pancharatnam-Berry phase coding metasurface (PBPCM) and ...
Abstract: In response to the specific requirements of space-borne gravitational wave detectors (SGWD) for laser frequency stability, this work systematically analyzes and investigates the frequency ...
Top Hungary news from today: African man almost killed in Budapest, Tibor Kapu heading to ISS, Wizz Air under scrutiny, Budapest faces crisis.
BACKGROUND: Fabry disease (FD) is an X-linked lysosomal storage disorder caused by α-Gal A (α-galactosidase A) deficiency, resulting in multiorgan accumulation of sphingolipid, namely ...